Dr. John Daniels MD Medical Oncologist

Dr. John Daniels is a medical oncologist in Los Angeles, California. He is affiliated with multiple hospitals in the area, including Keck Hospital of USC and University of Southern California-Norris Cancer Hospital. He received his medical degree from Stanford University School of Medicine and has been in practice for 50 years. Dr. Daniels accepts several types of health insurance, listed below. He is one of 14 doctors at Keck Hospital of USC and one of 8 at University of Southern California-Norris Cancer Hospital who specialize in Medical Oncology.

Are you Dr. John Daniels? Claim your profile to make edits or add details. Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Medical Oncologist: General Oncology

Hospital Affiliation

Keck Hospital of USC
High performing in Cancer

University of Southern California-Norris Cancer Hospital
Ranked #48 in Cancer

Education & Medical Training

Stanford University
Residency, Internal Medicine, 1964 - 1966

Stanford University
Residency, Internal Medicine, 1969 - 1970

Stanford University School of Medicine
Class of 1964

Certifications & Licensure

American Board of Internal Medicine
Certified 12 years in Internal Medicine

American Board of Internal Medicine
Certified 9 years in Endocrinology, Diabetes and Metabolism

MA State Medical License
Active through 2013

Publications & Presentations

Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 1: Development of a potent and CNS penetrant [3.1.0]-based lead.
Jones, C. K.,Sheffler, D. J.,Williams, R.,Jadhav, S. B.,Felts, A. S.,Morrison, R. D.,Niswender, C. M.,Daniels, J. S.,Conn, P. J.,Lindsley, C. W.

Discovery of the First M5-Selective and CNS Penetrant Negative Allosteric Modulator (NAM) of a Muscarinic Acetylcholine Receptor: (S)-9b-(4-Chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375).
Gentry, P. R.,Kokubo, M.,Bridges, T. M.,Kett, N. R.,Harp, J. M.,Cho, H. P.,Smith, E.,Chase, P.,Hodder, P. S.,Niswender, C. M.,Daniels, J. S.,Conn, P. J.,Wood, M. R.,Lindsley, C. W.

Discovery of the First M5-Selective and CNS Penetrant Negative Allosteric Modulator (NAM) of a Muscarinic Acetylcholine Receptor: (S)-9b-(4-Chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375).
Gentry, P. R.,Kokubo, M.,Bridges, T. M.,Kett, N. R.,Harp, J. M.,Cho, H. P.,Smith, E.,Chase, P.,Hodder, P. S.,Niswender, C. M.,Daniels, J. S.,Conn, P. J.,Wood, M. R.,Lindsley, C. W.

See all 12 publications

Insurances Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • AmeriHealth Direct POS
  • AmeriHealth Direct POS Value Network
  • Amerihealth HMO
  • AmeriHealth HMO Value Network
  • AmeriHealth PPO
  • AmeriHealth PPO Value Network
  • BCBS Blue Card PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • First Health PPO
  • GHI PPO
  • Great West PPO
  • HIP of New York - Select PPO
  • Horizon BCBS Direct Access
  • Horizon BCBS HMO
  • Horizon BCBS POS
  • Horizon BCBS PPO
  • Humana ChoiceCare Network PPO
  • Oxford Health Freedom
  • Oxford Health Liberty
  • QualCare HMO
  • QualCare PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by

Specialty

Location

Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.